Oova is the fertility translator that fully illuminates a woman's fertility, giving her and her care team the clearest steps to conception. Founded by doctors and backed by Mount Sinai Hospital, Oova has created a consumer-first, data-driven experience valuable to patients and healthcare providers. Oova's at-home urine test measures luteinizing hormone and progesterone to immediately inform a woman of her most fertile days and confirm ovulation. By delivering advanced personalized analytics and real-time action plans with every hormone reading, Oova is transforming the fertility care experience. Oova has partnered with the leading fertility and women's health practices in the United States.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
06/13/23	$10,300,000	Series A	Connecticut Innovations Hannah Bronfman Jefferson Health Samsung NEXT Sara Blakely Special Situation Funds Spero Ventures US Fertility Virgin Group	undisclosed